NanoString Technologies has named Alessandra Cesano as chief medical officer. Cesano most recently served as CMO at Cleave Bioscience. Prior to that, she was CMO and chief operations officer at Nodality. She has also held various management positions at Biogen Idec, Amgen, and SmithKline Beecham Pharmaceuticals. Cesano has also served as a visiting professor at the School of Oncology and School of Biotechnology at the University of Turin.